EntryPoint Capital’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$452K Hold
4,706
0.11% 363
2026
Q1
$514K Sell
4,706
-834
-15% -$79.5K 0.15% 232
2025
Q4
$449K Buy
+5,540
New +$477K 0.18% 208
2025
Q3
Sell
-5,580
Closed -$463K 788
2025
Q2
$463K Buy
5,580
+142
+3% +$11.9K 0.23% 125
2025
Q1
$456K Buy
5,438
+998
+22% +$92.8K 0.21% 132
2024
Q4
$409K Buy
4,440
+1,633
+58% +$157K 0.17% 196
2024
Q3
$261K Sell
2,807
-1,668
-37% -$145K 0.15% 309
2024
Q2
$368K Buy
+4,475
New +$329K 0.17% 103
2024
Q1
Sell
-80
Closed -$4.54K 1605
2023
Q4
$4.54K Buy
+80
New +$4.19K ﹤0.01% 1227

Other funds holding LMAT

EntryPoint Capital's LMAT Position: Q2 2026 in Review

EntryPoint Capital held its LeMaitre Vascular (LMAT) position steady in Q2 2026 at 4,706 shares worth $452K. The position accounts for 0.11% of the portfolio, ranked #363.

EntryPoint Capital first reported a position in LMAT in Q4 2023 and has held it in 9 quarters since. The position peaked at $514K in Q1 2026. 327 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • EntryPoint Capital held 4,706 shares of LeMaitre Vascular worth $452K as of Q2 2026.
  • EntryPoint Capital left its LeMaitre Vascular share count unchanged in Q2 2026.
  • LeMaitre Vascular made up 0.11% of EntryPoint Capital's portfolio in Q2 2026, its #363 holding.
  • EntryPoint Capital first reported a position in LeMaitre Vascular in Q4 2023 and has held it in 9 quarters since.
  • EntryPoint Capital's LeMaitre Vascular position peaked at $514K in Q1 2026.
  • 327 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on EntryPoint Capital's 13F filing for Q2 2026, filed 13 Aug 2026.